Via Patent Baristas

“The U.S. Senate Judiciary Committee voted to pass a compromise version of the bill by members Herb Kohl (D-WI) and Chuck Grassley (R-IA) banning pay-for-delay settlements that keep generic drugs off the market. The “Preserve Access to Affordable Generics Act (S.396)” is an attempt to reduce the anti-consumer practice of brand-name drug manufacturers using pay-off agreements to keep cheaper generic equivalents off the market by making the practice illegal.

“Under these pay-off agreements, brand name drug companies settle patent disputes by paying the generic drug manufacturer millions of dollars in exchange for a promise that it will keep its version of the drug off the market.”

To read the latest blog entry from Stephen Albainy-Jenei at Patent Baristas, click here.